Assessing human risk to heterocyclic amines

Area of Science:

• Toxicology
• Metabolism
• Carcinogenesis

Background:

• Heterocyclic amines (HAs), including MeIQx and PhIP, are genotoxic compounds formed during meat cooking.
• These HAs are found at low levels (part per billion) in cooked meats.

Purpose of the Study:

• To investigate the absorption, metabolism, and activation pathways of MeIQx and PhIP in humans.
• To compare human metabolism of HAs with that observed in laboratory animals.
• To assess the role of CYP1A2 in HA activation and its implications for diet-related cancer risk.

Main Methods:

• Gas chromatography/mass spectrometry (GC/MS) with stable isotope-labeled analogues was used to quantify MeIQx and PhIP.
• The effect of furafylline, a selective CYP1A2 inhibitor, on HA metabolism was examined in vitro and in human volunteers.
• Mutational analysis in mammalian cells (hprt gene) and comparison with tumor mutations (Apc gene in rat tumors).

Main Results:

• MeIQx and PhIP are efficiently absorbed into systemic circulation after consuming fried beef.
• CYP1A2-mediated N-hydroxylation is the primary activation pathway for MeIQx and PhIP in humans, leading to mutagenic species.
• Furafylline administration significantly inhibited the elimination of MeIQx (>90%) and PhIP (~70%) in human volunteers.
• PhIP induces a distinct mutational fingerprint in mammalian cells, matching mutations found in PhIP-induced rat colon tumors.

Conclusions:

• Human metabolism of MeIQx and PhIP, particularly CYP1A2 activation, differs significantly from animal models.
• These findings support a link between dietary HA exposure and cancer, highlighting species-specific metabolic differences.
• Animal study data may not accurately reflect human risk from heterocyclic amine exposure.